In this Issue:
Cardioselective beta-blockers are safe during acute exacerbations
Tiotropium in early-stage COPD
Statins and mortality in COPD
COPD patients have lower growth differentiation factor 11 levels
Cardiovascular and neuropsychiatric safety of varenicline and bupropion
Seasonal dynamics of airway pathogens
Treating breathlessness via the brain
Why is triple therapy used in newly diagnosed patients?
Self-management behaviours that reduce exacerbation impact
Obesity and acute exacerbations
Please login below to download this issue (PDF)